Lemuel Aigbivbalu – Projects/Grants — UTMB Health Research Expert Profiles

View Scopus Profile

Emailleaigbivutmbedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

1 Active
11 Completed

12 results

Active

A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19
Aigbivbalu, L.
10/1/21 → 9/30/26
Project: Other project
Completed

CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
DUKE UNIVERSITY
12/5/13 → 5/23/15
Project: Other project
CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
12/5/13 → 5/23/15
Project: Other project
CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
DUKE UNIVERSITY
12/5/13 → 5/23/15
Project: Other project
CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
12/5/13 → 5/23/15
Project: Other project
CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
12/5/13 → 5/23/15
Project: Other project
CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection
Aigbivbalu, L.
12/5/13 → 5/23/15
Project: Other project
A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections
Aigbivbalu, L.
11/13/13 → 11/12/15
Project: Other project
A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections
Aigbivbalu, L.
DUKE UNIVERSITY
11/13/13 → 11/12/15
Project: Other project
A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections¿
Aigbivbalu, L.
11/13/13 → 11/12/15
Project: Other project
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19
Aigbivbalu, L.
1/1/00 → 1/1/00
Project: Other project
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19
Aigbivbalu, L.
Eli Lilly
1/1/00 → 1/1/00
Project: Other project